ADJUVANT THERAPY
Clinical trials for ADJUVANT THERAPY explained in plain language.
Never miss a new study
Get alerted when new ADJUVANT THERAPY trials appear
Sign up with your email to follow new studies for ADJUVANT THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to stop aggressive breast cancer from returning
Disease control Recruiting nowThis study is testing whether adding an immunotherapy drug called QL1706 to standard chemotherapy after surgery can help prevent high-risk triple-negative breast cancer from coming back. About 59 women with this aggressive cancer type will receive the combination treatment, follo…
Matched conditions: ADJUVANT THERAPY
Phase: NA • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Supercharged immune cells take on solid tumors in early trial
Disease control Recruiting nowThis early-stage trial is testing a new type of immune cell therapy called armored dendritic cells in 8 people with solid cancers like pancreatic or colorectal cancer. Participants have already had surgery and at least 4 rounds of chemotherapy. The goal is to see if the treatment…
Matched conditions: ADJUVANT THERAPY
Phase: PHASE1 • Sponsor: Shanghai Cell Therapy Group Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New hope for High-Risk breast cancer: drug combo aims to stop recurrence
Disease control Recruiting nowThis study tests whether adding a CDK4/6 inhibitor to standard hormone therapy can help prevent breast cancer from coming back in high-risk patients with HR+/HER2+ early breast cancer. About 1,900 women aged 18-70 who have already completed anti-HER2 therapy will be randomly assi…
Matched conditions: ADJUVANT THERAPY
Phase: PHASE3 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Sitting less during cancer care: new study tests digital fix
Symptom relief Recruiting nowThis study tests whether a digital support program can help people with breast, prostate, or colorectal cancer reduce the time they spend sitting during their treatment. The goal is to improve their well-being and lower future health risks. About 172 participants will use an acti…
Matched conditions: ADJUVANT THERAPY
Phase: NA • Sponsor: Mälardalen University • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New study tracks breast cancer return in patients on targeted therapy
Knowledge-focused Recruiting nowThis study observes 750 people with a common type of breast cancer who have already been treated with surgery and are now taking CDK4/6 inhibitors to lower the risk of cancer coming back. Researchers will track how many patients experience a relapse and how well they do over time…
Matched conditions: ADJUVANT THERAPY
Sponsor: European Institute of Oncology • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC